SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-311777
Filing Date
2022-12-23
Accepted
2022-12-23 16:07:05
Documents
15
Period of Report
2022-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d402595d8k.htm   iXBRL 8-K 30383
2 EX-1.1 d402595dex11.htm EX-1.1 185353
3 EX-5.1 d402595dex51.htm EX-5.1 10727
7 GRAPHIC g402595page42a.jpg GRAPHIC 8058
  Complete submission text file 0001193125-22-311777.txt   420838

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vor-20221223.xsd EX-101.SCH 2852
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20221223_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20221223_pre.xml EX-101.PRE 11710
9 EXTRACTED XBRL INSTANCE DOCUMENT d402595d8k_htm.xml XML 3468
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 221485430
SIC: 2836 Biological Products, (No Diagnostic Substances)